Screening to Identify Commonly Used Chinese Herbs That Affect ERBB2 and ESR1 Gene Expression Using the Human Breast Cancer MCF-7 Cell Line.
Jen-Hwey ChiuChun-Ju ChangJing-Chong WuHui-Ju LiuChe-Sheng WenChung-Hua HsuJiun-Liang ChenLing Ming TsengWei-Shone ChenYi-Ming ShyrPublished in: Evidence-based complementary and alternative medicine : eCAM (2014)
Aim. Our aim the was to screen the commonly used Chinese herbs in order to detect changes in ERBB2 and ESR1 gene expression using MCF-7 cells. Methods. Using the MCF-7 human breast cancer cell line, cell cytotoxicity and proliferation were evaluated by MTT and trypan blue exclusion assays, respectively. A luciferase reporter assay was established by transient transfecting MCF-7 cells with plasmids containing either the ERBB2 or the ESR1 promoter region linked to the luciferase gene. Chinese herbal extracts were used to treat the cells at 24 h after transfection, followed by measurement of their luciferase activity. The screening results were verified by Western blotting to measure HER2 and ER α protein expression. Results. At concentrations that induced little cytotoxicity, thirteen single herbal extracts and five compound recipes were found to increase either ERBB2 or ESR1 luciferase activity. By Western blotting, Si-Wu-Tang, Kuan-Shin-Yin, and Suan-Tsao-Ren-Tang were found to increase either HER2 or ER α protein expression. In addition, Ligusticum chuanxiong was shown to have a great effect on ERBB2 gene expression and synergistically with estrogen to stimulate MCF-7 cell growth. Conclusion. Our results provide important information that should affect clinical treatment strategies among breast cancer patients who are receiving hormonal or targeted therapies.
Keyphrases
- gene expression
- breast cancer cells
- estrogen receptor
- induced apoptosis
- dna methylation
- tyrosine kinase
- cell cycle arrest
- endothelial cells
- high throughput
- signaling pathway
- south africa
- escherichia coli
- type diabetes
- crispr cas
- adipose tissue
- stem cells
- induced pluripotent stem cells
- insulin resistance
- bone marrow
- metabolic syndrome
- mesenchymal stem cells
- skeletal muscle
- pi k akt
- polycystic ovary syndrome